_MEMBER_Geneid,_LogP_Geneid,GO,Description,_PATTERN_,_RANK_,GiniIndex
1,-2.4,GO:0007167,enzyme linked receptor protein signaling pathway,M1,1,0
1,-3.5,GO:1901342,regulation of vasculature development,M1,1,0
1,-2.1,GO:0072132,mesenchyme morphogenesis,M1,1,0
1,-3,GO:0043392,negative regulation of DNA binding,M1,1,0
1,-2,R-MMU-380108,Chemokine receptors bind chemokines,M1,1,0
1,-2.2,WP1261,ErbB signaling pathway,M1,1,0
1,-5.1,GO:0007179,transforming growth factor beta receptor signaling pathway,M1,1,0
1,-3.8,WP85,Focal adhesion,M1,1,0
1,-2.6,GO:0110020,regulation of actomyosin structure organization,M1,1,0
1,-3.2,GO:0001775,cell activation,M1,1,0
1,-2.5,GO:0051100,negative regulation of binding,M1,1,0
1,-3.1,GO:0044042,glucan metabolic process,M1,1,0
1,-2.9,GO:0033555,multicellular organismal response to stress,M1,1,0
1,-2.1,GO:0009409,response to cold,M1,1,0
1,-3.3,GO:0051965,positive regulation of synapse assembly,M1,1,0
1,-2.9,GO:0048634,regulation of muscle organ development,M1,1,0
1,-4.6,R-MMU-4086398,Ca2+ pathway,M1,1,0
1,-2.3,GO:0030835,negative regulation of actin filament depolymerization,M1,1,0
1,-2,mmu04916,Melanogenesis,M1,1,0
1,-2.2,GO:0090257,regulation of muscle system process,M1,1,0
1,-3.1,GO:0006073,cellular glucan metabolic process,M1,1,0
1,-2.4,GO:0050873,brown fat cell differentiation,M1,1,0
1,-3.3,mmu04650,Natural killer cell mediated cytotoxicity,M1,1,0
1,-2.8,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2.1,mmu05205,Proteoglycans in cancer,M1,1,0
1,-2.6,GO:0032231,regulation of actin filament bundle assembly,M1,1,0
1,-2.2,GO:0045638,negative regulation of myeloid cell differentiation,M1,1,0
1,-3.4,mmu05100,Bacterial invasion of epithelial cells,M1,1,0
1,-2.1,GO:0045646,regulation of erythrocyte differentiation,M1,1,0
1,-2.4,GO:0045766,positive regulation of angiogenesis,M1,1,0
1,-2.8,GO:0045599,negative regulation of fat cell differentiation,M1,1,0
1,-2.2,GO:0032870,cellular response to hormone stimulus,M1,1,0
1,-2,GO:0030335,positive regulation of cell migration,M1,1,0
1,-2.8,GO:0006112,energy reserve metabolic process,M1,1,0
1,-2.1,GO:0044057,regulation of system process,M1,1,0
1,-2.3,WP265,Delta-Notch signaling pathway,M1,1,0
1,-4,mmu04310,Wnt signaling pathway,M1,1,0
1,-2.4,mmu05216,Thyroid cancer,M1,1,0
1,-2.5,GO:0010611,regulation of cardiac muscle hypertrophy,M1,1,0
1,-2.2,GO:0046777,protein autophosphorylation,M1,1,0
1,-2.3,GO:0097722,sperm motility,M1,1,0
1,-4.9,GO:0045596,negative regulation of cell differentiation,M1,1,0
1,-3,GO:0050773,regulation of dendrite development,M1,1,0
1,-2.3,GO:0015800,acidic amino acid transport,M1,1,0
1,-2.2,mmu05210,Colorectal cancer,M1,1,0
1,-3.3,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,M1,1,0
1,-2.1,mmu04350,TGF-beta signaling pathway,M1,1,0
1,-3.1,GO:1901653,cellular response to peptide,M1,1,0
1,-2.2,GO:0060294,cilium movement involved in cell motility,M1,1,0
1,-4.2,WP512,Id signaling pathway,M1,1,0
1,-2.5,R-MMU-74752,Signaling by Insulin receptor,M1,1,0
1,-3.2,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,M1,1,0
1,-2.1,GO:0030855,epithelial cell differentiation,M1,1,0
1,-2.1,GO:0045429,positive regulation of nitric oxide biosynthetic process,M1,1,0
1,-2.3,GO:0008285,negative regulation of cell population proliferation,M1,1,0
1,-4.2,R-MMU-4641265,Repression of WNT target genes,M1,1,0
1,-2.4,GO:1904018,positive regulation of vasculature development,M1,1,0
1,-2.3,GO:0010762,regulation of fibroblast migration,M1,1,0
1,-2,GO:0071900,regulation of protein serine/threonine kinase activity,M1,1,0
1,-2.8,GO:0051492,regulation of stress fiber assembly,M1,1,0
1,-2.7,GO:0007288,sperm axoneme assembly,M1,1,0
1,-2.4,GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,M1,1,0
1,-2.3,GO:0030317,flagellated sperm motility,M1,1,0
1,-3.1,GO:0005977,glycogen metabolic process,M1,1,0
1,-2.6,R-MMU-389356,CD28 co-stimulation,M1,1,0
1,-3.3,GO:0008217,regulation of blood pressure,M1,1,0
1,-2.6,GO:0045637,regulation of myeloid cell differentiation,M1,1,0
1,-2.1,GO:0022604,regulation of cell morphogenesis,M1,1,0
1,-2,WP113,TGF-beta signaling pathway,M1,1,0
1,-3.3,GO:0035239,tube morphogenesis,M1,1,0
1,-3.3,R-MMU-3858494,Beta-catenin independent WNT signaling,M1,1,0
1,-2.2,GO:0045926,negative regulation of growth,M1,1,0
1,-2,GO:0003007,heart morphogenesis,M1,1,0
1,-2.8,GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,M1,1,0
1,-3.2,GO:1901890,positive regulation of cell junction assembly,M1,1,0
1,-2,mmu04921,Oxytocin signaling pathway,M1,1,0
1,-3.3,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,M1,1,0
1,-2.5,GO:0120316,sperm flagellum assembly,M1,1,0
1,-2.5,GO:0051693,actin filament capping,M1,1,0
1,-2.8,mmu04933,AGE-RAGE signaling pathway in diabetic complications,M1,1,0
1,-2.4,GO:0002287,alpha-beta T cell activation involved in immune response,M1,1,0
1,-2.1,GO:0035082,axoneme assembly,M1,1,0
1,-2.5,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",M1,1,0
1,-3.5,GO:1903670,regulation of sprouting angiogenesis,M1,1,0
1,-3.2,mmu05200,Pathways in cancer,M1,1,0
1,-2,R-MMU-372790,Signaling by GPCR,M1,1,0
1,-3.1,GO:0048660,regulation of smooth muscle cell proliferation,M1,1,0
1,-2.7,GO:0050678,regulation of epithelial cell proliferation,M1,1,0
1,-3,GO:0001678,cellular glucose homeostasis,M1,1,0
1,-2.3,GO:0000904,cell morphogenesis involved in differentiation,M1,1,0
1,-2.3,GO:0048265,response to pain,M1,1,0
1,-2.7,R-MMU-3769402,Deactivation of the beta-catenin transactivating complex,M1,1,0
1,-2.2,GO:0046621,negative regulation of organ growth,M1,1,0
1,-2.9,mmu04062,Chemokine signaling pathway,M1,1,0
1,-2.2,GO:0030155,regulation of cell adhesion,M1,1,0
1,-2.3,GO:0034110,regulation of homotypic cell-cell adhesion,M1,1,0
1,-3,GO:0071375,cellular response to peptide hormone stimulus,M1,1,0
1,-2.3,GO:0050767,regulation of neurogenesis,M1,1,0
1,-3.1,GO:0000902,cell morphogenesis,M1,1,0
1,-2.1,R-MMU-1660499,Synthesis of PIPs at the plasma membrane,M1,1,0
1,-2.2,GO:0048534,hematopoietic or lymphoid organ development,M1,1,0
1,-2.7,GO:0048661,positive regulation of smooth muscle cell proliferation,M1,1,0
1,-2.6,GO:0150116,regulation of cell-substrate junction organization,M1,1,0
1,-2.5,GO:0042093,T-helper cell differentiation,M1,1,0
1,-2.3,GO:0045321,leukocyte activation,M1,1,0
1,-2.2,GO:0002761,regulation of myeloid leukocyte differentiation,M1,1,0
1,-2.6,GO:0110053,regulation of actin filament organization,M1,1,0
1,-2.6,GO:0045668,negative regulation of osteoblast differentiation,M1,1,0
1,-2.2,GO:0007423,sensory organ development,M1,1,0
1,-3,GO:0090287,regulation of cellular response to growth factor stimulus,M1,1,0
1,-2.2,GO:0032869,cellular response to insulin stimulus,M1,1,0
1,-2.7,mmu05146,Amoebiasis,M1,1,0
1,-2.1,GO:0050921,positive regulation of chemotaxis,M1,1,0
1,-2.6,GO:0055082,cellular chemical homeostasis,M1,1,0
1,-2,R-MMU-2424491,DAP12 signaling,M1,1,0
1,-2.6,mmu04720,Long-term potentiation,M1,1,0
1,-2.2,GO:1903522,regulation of blood circulation,M1,1,0
1,-2.1,WP553,Calcium regulation in cardiac cells,M1,1,0
1,-2.3,mmu04068,FoxO signaling pathway,M1,1,0
1,-3.1,GO:0007528,neuromuscular junction development,M1,1,0
1,-3.9,mmu05213,Endometrial cancer,M1,1,0
1,-2.7,GO:0061003,positive regulation of dendritic spine morphogenesis,M1,1,0
1,-2.1,GO:0032970,regulation of actin filament-based process,M1,1,0
1,-2.4,GO:0048640,negative regulation of developmental growth,M1,1,0
1,-4.4,GO:0003013,circulatory system process,M1,1,0
1,-2.1,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",M1,1,0
1,-2.6,R-MMU-9006934,Signaling by Receptor Tyrosine Kinases,M1,1,0
1,-3,GO:0042088,T-helper 1 type immune response,M1,1,0
1,-2.1,GO:0022408,negative regulation of cell-cell adhesion,M1,1,0
1,-2.2,GO:0043405,regulation of MAP kinase activity,M1,1,0
1,-2.7,GO:0051098,regulation of binding,M1,1,0
1,-3.3,GO:1901888,regulation of cell junction assembly,M1,1,0
1,-3,R-MMU-201722,Formation of the beta-catenin:TCF transactivating complex,M1,1,0
1,-3.9,GO:1901861,regulation of muscle tissue development,M1,1,0
1,-2.6,GO:0010975,regulation of neuron projection development,M1,1,0
1,-2.1,GO:0044262,cellular carbohydrate metabolic process,M1,1,0
1,-2.8,GO:0045598,regulation of fat cell differentiation,M1,1,0
1,-2.8,R-MMU-8874081,MET activates PTK2 signaling,M1,1,0
1,-3.2,GO:0010718,positive regulation of epithelial to mesenchymal transition,M1,1,0
1,-3.6,GO:0045765,regulation of angiogenesis,M1,1,0
1,-2.4,GO:0120035,regulation of plasma membrane bounded cell projection organization,M1,1,0
1,-2.4,GO:0002293,alpha-beta T cell differentiation involved in immune response,M1,1,0
1,-3.6,mmu05226,Gastric cancer,M1,1,0
1,-3.1,WP2292,Chemokine signaling pathway,M1,1,0
1,-3.3,GO:0051963,regulation of synapse assembly,M1,1,0
1,-3.9,GO:0043471,regulation of cellular carbohydrate catabolic process,M1,1,0
1,-3.9,GO:0071559,response to transforming growth factor beta,M1,1,0
1,-3,GO:0099170,postsynaptic modulation of chemical synaptic transmission,M1,1,0
1,-2.1,GO:1904407,positive regulation of nitric oxide metabolic process,M1,1,0
1,-2.7,GO:0014911,positive regulation of smooth muscle cell migration,M1,1,0
1,-2.4,GO:0014743,regulation of muscle hypertrophy,M1,1,0
1,-2,GO:1901652,response to peptide,M1,1,0
1,-3.4,mmu04390,Hippo signaling pathway,M1,1,0
1,-3.1,GO:0051960,regulation of nervous system development,M1,1,0
1,-2.2,GO:0046649,lymphocyte activation,M1,1,0
1,-2.6,GO:0060479,lung cell differentiation,M1,1,0
1,-2.1,GO:0014910,regulation of smooth muscle cell migration,M1,1,0
1,-3,mmu05222,Small cell lung cancer,M1,1,0
1,-2.5,R-MMU-6806834,Signaling by MET,M1,1,0
1,-2.1,WP523,Regulation of actin cytoskeleton,M1,1,0
1,-2.7,GO:0050803,regulation of synapse structure or activity,M1,1,0
1,-2.5,GO:0005976,polysaccharide metabolic process,M1,1,0
1,-2.8,GO:0001539,cilium or flagellum-dependent cell motility,M1,1,0
1,-2.2,GO:0051588,regulation of neurotransmitter transport,M1,1,0
1,-2.6,mmu04931,Insulin resistance,M1,1,0
1,-3.9,GO:0048814,regulation of dendrite morphogenesis,M1,1,0
1,-3,GO:0016202,regulation of striated muscle tissue development,M1,1,0
1,-2.2,GO:0008016,regulation of heart contraction,M1,1,0
1,-2.1,GO:0046631,alpha-beta T cell activation,M1,1,0
1,-2.1,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,M1,1,0
1,-3.5,mmu04510,Focal adhesion,M1,1,0
1,-2.4,R-MMU-8875878,MET promotes cell motility,M1,1,0
1,-4.1,GO:0008015,blood circulation,M1,1,0
1,-3.5,mmu04520,Adherens junction,M1,1,0
1,-2.9,GO:0043470,regulation of carbohydrate catabolic process,M1,1,0
1,-2.4,mmu04360,Axon guidance,M1,1,0
1,-2.3,GO:0031344,regulation of cell projection organization,M1,1,0
1,-4,GO:0071560,cellular response to transforming growth factor beta stimulus,M1,1,0
1,-2.6,GO:0060487,lung epithelial cell differentiation,M1,1,0
1,-2.3,GO:0002292,T cell differentiation involved in immune response,M1,1,0
1,-2.6,WP488,Alpha 6 beta 4 integrin signaling pathway,M1,1,0
1,-3,GO:0051962,positive regulation of nervous system development,M1,1,0
1,-2.5,R-MMU-195721,Signaling by WNT,M1,1,0
1,-2.1,GO:0010717,regulation of epithelial to mesenchymal transition,M1,1,0
1,-3.2,mmu04012,ErbB signaling pathway,M1,1,0
1,-2.8,WP2432,Spinal cord injury,M1,1,0
1,-2.5,GO:0046824,positive regulation of nucleocytoplasmic transport,M1,1,0
1,-3.8,GO:0045063,T-helper 1 cell differentiation,M1,1,0
1,-3.6,GO:0006468,protein phosphorylation,M1,1,0
1,-2.8,GO:0050807,regulation of synapse organization,M1,1,0
1,-2.6,GO:0044264,cellular polysaccharide metabolic process,M1,1,0
1,-2.9,mmu04370,VEGF signaling pathway,M1,1,0
1,-2.8,GO:0060285,cilium-dependent cell motility,M1,1,0
1,-2.2,GO:0060428,lung epithelium development,M1,1,0
